If you need more lookups,
subscriptions start at $34 USD/month.
Christopher McCloskey Location
Philadelphia, PA, US
Christopher McCloskey Work
President @ (February 2026 - Present)
Executive Vice President @ (October 2024 - November 2025)
Sr. Director, Transplant Services and Business Development @ (May 2023 - October 2024)
Director Of Business Development @ (February 2022 - May 2023)
Senior Manager, Strategy and Market Access @ (April 2021 - February 2022)
Vice President Of Product Development @ ActiCare Health (September 2015 - April 2021)
Chronic Care Strategy, Consultant @ (May 2014 - August 2014)
Director, Corporate Communications @ (July 2010 - July 2013)
Senior Manager, Corporate Finance @ (December 2008 - July 2010)
Commercial Analytics Manager @ (February 2006 - December 2008)
Analyst @ (September 2004 - December 2005)
Christopher McCloskey Education
Harvard School of Public Health
Master of Public Health (M.P.H.)
2013-2015
University of Pennsylvania
Bachelor of Arts (B.A.)
2000-2004
Christopher McCloskey Skills
Strategic Planning
Mergers
Strategy
Management
Mergers & Acquisitions
Marketing Communications
Leadership
CRM
Marketing
Healthcare
Sales
Process Improvement
Analytics
Training
Public Relations
Finance
New Business Development
Corporate Communications
Cross-functional Team Leadership
Start-ups
Medical Devices
Start Ups
Business Development
Cross Functional Team Leadership
Mergers and Acquisitions
Christopher McCloskey Summary
Christopher McCloskey, based in Philadelphia, PA, US, is currently a President at Eurofins Transplant Genomics. Christopher McCloskey brings experience from previous roles at PIRCHE and Thermo Fisher Scientific. Christopher McCloskey holds a 2013 - 2015 Master of Public Health (M.P.H.) @ Harvard School of Public Health. With a robust skill set that includes Strategic Planning, Mergers, Strategy, Management, Mergers & Acquisitions and more. Christopher McCloskey has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Christopher McCloskey?
Find contact details for 700 million professionals.